Boron Neutron Capture Therapy is a very promising form of cancer therapy, consisting in irradiating a stable isotope of boron ( 10 B) concentrated in tumor cells with a low energy neutron beam. This technique makes it possible to destroy tumor cells, leaving healthy tissues practically unaffected. In order to carry out the therapy in the proper way, the proper range of the neutron beam energy has to be chosen.
Introduction
BNCT (Boron Neutron Capture Therapy) is a form of radiotherapy that held promise of being beneficial to cancer patients with glioma, a type of brain cancer. This type of tumor is quite resistant to other treatment modalities and the prospects of its cure are very poor.
An ideal therapy for cancer would be one whereby all tumor cells were selectively destroyed without damaging normal tissues.
BNCT brings together two components that, when kept separate, have only minor effects on cells. The first component is a stable isotope of boron (boron-10) that can be concentrated in tumor cells by being attached to tumor-seeking compounds. The second one is a beam of low-energy neutrons. Boron-10 in or adjacent to tumor cells disintegrates after capturing a neutron. The high-energy, heavy charged particles produced destroy only the cells, primarily cancer cells, in close proximity to the vertex, leaving adjacent normal cells largely unaffected.
The dose absorbed by the tissue in BNCT consists of four components: 1. The gamma ray dose from the gamma ray component of the beam and the gamma rays induced in the tissue, mainly due to 1 H(n,g) 2 H reactions emitting 2.2 MeV gamma rays.
2. The fast neutron dose epithermal and fast neutrons that cause "knock-out" recoil protons from hydrogen in tissue. 3. The nitrogen dose from 14 N absorbing a thermal neutron and emitting 0.6 MeV a proton in 14 N(n,p) 14 C reaction.
4. The boron dose from 10 B absorbing a thermal neutron in a 10 B(n,a) 7 Li reaction. The emitted a particle and the recoiling 7 Li ion result in locally deposited energy, averaging about 2.34 MeV. In 94% of the reactions the recoiling 7 Li ion is produced in an excited state and de-excites emitting a 477 keV gamma ray. In the remaining 6% of events, 7 Li ion is emitted in the ground state.
The only usable component from the therapeutic point of view is the boron component, therefore we want the boron dose to be as large as possible while other components are kept minimal. Among other contributions of the absorbed dose, those most significant from the dosimetry perspective are the nitrogen dose and the 2.2 MeV gamma dose from the hydrogen capture.
If the tumor tissue is situated in the brain at a depth of about 2-3 cm, the most usable neutrons are those epithermal ones with energies of 0.5 eV-10 keV. They are moderated in the tissue between the skin and the tumor cells and they gain thermal energies (below 0.5 eV), when reaching the tumor tissue (the cross-section for the reaction with 10 B is inversely proportional to neutron velocity). Direct irradiation with a thermal neutron beam would cause a big irradiation of the healthy tissue on the surface and there would be insufficient number of neutrons reaching the tumor tissue.
In order to obtain the optimum energy of the beam, one has to use a system of filters and moderators.
The aim of our analysis was to find, using the MCNP code, what beam energy value is optimal for the therapy.
Method
The model of the head was defined within the code as a 20-cm diameter sphere of tissue-like material (ICRU brain) consisting of hydrogen (10.7%), carbon (14.5%), nitrogen (2.2%), oxygen (71.2%), sodium (0.2%), phosphorus (0.4%), sulfur (0.2%), chlorine (0.3%) and potassium (0.3%) of the density of 1.04 g/cm 3 . The sphere was divided into 60 pieces of various size: 6 layers of concentric, cylindrical cells up to the depth of 7 cm, and the rest of the head defined as one cell (Figure 1 ).
The energy of the neutron beam ranged between 1 eV and 1 MeV. The beam was ideally collimated, pointing to the center of the head.
In order to study the dependence of the boron dose on the beam energy, we added isotropically 10 B to the brain tissue material. The fraction matched the one used in the therapy that is 0.003%, which corresponds to the mean free path of 1.5 m. Results and discussion Figure 2 shows the dependence of the absorbed boron dose on the depth and the distance from the beam axis for chosen energy values. As expected, the maximum dose depth increased with increasing beam energy. At the energy of 1 keV, the maximum dose was absorbed at the depth of 2-3 cm, which corresponds to a typical tumor situation. For layer 4, corresponding to the typical tumor depth, the dependence is monotonic.
In order to study the gamma and nitrogen doses, we used ICRU brain material without the boron fraction. We made the assumption that a 0.6 MeV proton will be stopped within the same cell it was produced (the range of 0.6 MeV protons in tissue is
. Figure 4 shows the dependence of the nitrogen dose on the depth and the distance from the beam for each of the energy values. Again -we obtained a strong dependence of the maximum dose depth on beam energy. In order to obtain the value of the gamma dose, mostly from the 2.2 MeV photons from the hydrogen capture reaction, we have calculated the energy deposited by photons in each cell and divided it by the mass of the cell.
Due to the properties of gamma radiation, the shape of the gamma dose dependence on the beam energy differs from that for other dose components under study. Like in those other components, the dose for the first layers decreases monotonically as a function of beam energy, but for the deepest layer there is a maximum dose absorbed at the beam energy of 1 keV.
In order to interpret these results correctly, one should realize that in the therapy the boron dose will be absorbed only in some selected (tumor) area, whereas the gamma and nitrogen doses will be absorbed in the patient's whole head. The average nitrogen and gamma injuring doses and their sum are presented in Figure 8 . One can see that for the whole head the gamma dose is one order of magnitude higher than the nitrogen dose, while the values obtained for the layers investigated were similar.
In order to determine the optimum beam energy range, one should compare the average injuring dose to the therapeutic dose absorbed in each of the layers. The result of this comparison is presented in Figure 9 .
136 Katarzyna Tymińska Figure 9 . The ratio of the therapeutic dose absorbed in each particular layer to the injuring dose averaged over the patient's whole head. The thick line corresponds to the values obtained for a typical tumor depth (layer 4).
Conclusions
Our results will be used to find an optimum beam energy range. For a more complete picture, the calculations concerning the fast neutron dose and the gamma dose from the beam should be taken into account. This will be done as the next step in our study.
